GlassScriptPhysician profile
Jacqueline Sitton
NPI 1295188340
$916.73
in general payments reported to CMS, 2019-2025
15 companies · $56.70 in 2025
The $56.70 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $298 · 2022: $215 · 2023: $237 · 2024: $109 · 2025: $56.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $351.66 | 2021-2024 | |
| Pfizer INC. | $92.26 | 2021-2023 | |
| Lilly USA, LLC | $88.07 | 2023-2024 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $86.39 | 2022-2023 | Rybelsus, Ozempic, Wegovy |
| Medtronic, INC. | $56.70 | 2025 | Inceptiv |
| Abbott Laboratories | $38.09 | 2023-2024 | Proclaim |
| Daiichi Sankyo INC. | $35.55 | 2022 | |
| Corium, LLC | $34.80 | 2023 | Azstarys |
| Boston Scientific Corporation | $29.72 | 2023 | Spaceoar Vue System - 10ml |
| Evofem Biosciences, INC. | $23.52 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.47 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $18.39 | 2021 | |
| Ibsa Pharma INC. | $15.11 | 2022 | |
| Currax Pharmaceuticals LLC | $13.96 | 2023 | Contrave |
| Organon LLC | $11.04 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Sitton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.